ClinicalTrials.Veeva
Menu

Find clinical trials for COVID-19 in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Human Influenza
Post-Acute COVID-19 Syndrome
Respiratory Distress Syndrome

COVID-19 trials near Birmingham, AL, USA:

Clinical Evaluation of the Panbio™ COVID-19/Flu A&B Panel to Support Home Use

This study is designed to demonstrate the performance and usability of the the Panbio™ COVID-19/Flu A\&B Panel Self Test in the han...

Enrolling
COVID-19
Influenza A
Diagnostic Test: Panbio™ COVID-19/Flu A&B Panel
Abbott
Abbott

Pelham, Alabama, United States and 1 other location

A Study of mRNA-1283.222 Injection Compared With mRNA-1273.222 Injection in Participants ≥12 Years of Age to Prevent COVID-19 (NextCOVE)

The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its...

Active, not recruiting
COVID-19
Biological: mRNA-1273.222
Biological: mRNA-1283.222

Phase 3

Moderna
Moderna

Vestavia Hills, Alabama, United States and 217 other locations

A Study to Evaluate EDP-235 in Non-hospitalized Adults With COVID-19 (SPRINT)

Study of EDP-235 in Non-hospitalized Adults with Mild or Moderate COVID-19....

Enrolling
COVID-19
Drug: Placebo
Drug: EDP-235

Phase 2

Enanta Pharmaceuticals
Enanta Pharmaceuticals

Birmingham, Alabama, United States and 20 other locations

Proof of Principle Study to Evaluate the Safety, PK, Viral Shedding and Efficacy of Pentarlandir™ UPPTA for Patients With Early COVID-19

This is a clinical trial to evaluate the safety, PK, viral shedding and clinical effects of Pentarlandir™ UPPTA in patients with early COVID-...

Enrolling
Coronavirus Disease 2019
Drug: Pentarlandir™ UPPTA
Drug: Placebo

Phase 2

SyneuRx

Cullman, Alabama, United States of America and 11 other locations

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Sub-study)
Biological: Placebo (Parent study Sentinel Safety Cohort)

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Birmingham, Alabama, United States and 214 other locations

Performance Evaluation of LumiraDx COVID-19 (SARS-CoV-2) Ag ULTRA Test (ASPIRE-2)

Performance of the LumiraDx SARS-CoV-2 Ag ULTRA assay will be assessed by comparison to a reference method

Active, not recruiting
COVID-19
Diagnostic Test: Nasopharyngeal swab
Diagnostic Test: Nasal Swab
LumiraDx

Birmingham, Alabama, United States and 5 other locations

A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19

be tolerated for treatment of pregnant women with mild or moderate COVID-19 compared to non-pregnant women with mild or moderate CO-...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 1

Pfizer
Pfizer

Birmingham, Alabama, United States and 32 other locations

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.

The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vacci-...

Active, not recruiting
COVID-19
Influenza
Biological: COVID-19 Vaccine
Biological: Influenza and COVID-19 Combination A

Phase 3

BioNTech
BioNTech

Birmingham, Alabama, United States and 157 other locations

Locations recently updated

EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease

study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...

Enrolling
COVID-19
Drug: nirmatrelvir
Drug: ritonavir

Phase 3

Pfizer
Pfizer

Birmingham, Alabama, United States and 105 other locations

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older (VAT00008)

The purpose of this Phase III study is to assess the efficacy, safety, and immunogenicity of two CoV2 preS dTM-AS03 vaccines (monovalent and bivalent...

Active, not recruiting
COVID-19
Biological: Placebo
Biological: SARS-CoV-2 adjuvanted recombinant protein vaccine(monovalent D614)(primary series)& SARS-CoV-2 adjuvanted recombinant protein vaccine(monovalent B.1.351)(booster dose)>=4 months after last vaccination

Phase 3

Sanofi
Sanofi

Birmingham, Alabama, United States and 93 other locations

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2024 Veeva Systems